
Merck Reports; Big Tech Earnings; Marvell-Lumentum Latest
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Merck (MRK) shares are moving after it raised its full-year profit forecast after third-quarter results topped Wall Street’s expectations, fueled by stronger-than-anticipated sales of cancer blockbuster Keytruda and other newer medicines. The company boosted the lower end of its full-year sales forecast by $500 million and now expects adjusted earnings for the year of $2.77 to $2.82 a share. Sales of Keytruda in both its formulations combined were $8.6 billion, and the company is also developing a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.